KYLE BROWN: Open Payments
NPI 1548537400 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 6 payments from 5 companies in 2025. Trend: 2023 $750 · 2024 $1,360 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 2 | $45 |
| ABBVIE INC. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Dyanavel XR, VRAYLAR, INSPIRE, REXULTI, INGREZZA.
Industry payments across CO — which companies pay providers there.
